Biggest Pharma Deal Ever Faces Aging Patents, Tough Politics
A technician inspects vaccine vials for defects during a screening process at a pharmaceutical plant in Pune, Maharashtra, India. (Photographer: Sanjit Das/Bloomberg)

Biggest Pharma Deal Ever Faces Aging Patents, Tough Politics

(Bloomberg) -- A record pharmaceutical deal between Bristol-Myers Squibb Co. and Celgene Corp. will face obstacles on several fronts, including expiring patents on Celgene’s cornerstone drug, criti...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.